Abstract
Schistosomiasis is a serious public health problem in many developing countries. Reports show the increasing emergence of resistant strains of Schistosomamansoni to praziquantel, the drug of choice for the treatment of schistosomiasis. In this context, the discovery of new compounds that can serve as models (prototypes) for the development of antischistosomal agents more efficient and les…